Lung cancer

Open Access
History of Chronic Obstructive Pulmonary Disease May Contribute to Earlier Diagnosis of Lung Cancer
MILOSLAV MAREL, PETR DOMECKY, CASAS MENDEZ LUIS FERNANDO, ALZBETA BEJCKOVA, LIBOR FILA, MICHAL HRNCIARIK, TOMAS VENCALEK, JAROMIR ROUBEC, JAROSLAV DUBA and MARTIN SVATON

In Vivo March 2026, 40 (2) 1153-1162; DOI: https://doi.org/10.21873/invivo.14270
Open Access
Ultra-low Concentrations of Cisplatinum Down to the IC₁₀ in Combination With Recombinant Methioninase Are Synergistically Effective Against Lung Cancer Cells In Vitro and In Vivo
YOHEI ASANO, QINGHONG HAN, SHUKUAN LI, BYUNG MO KANG, JIN SOO KIM, YUTA MIYASHI, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, SEI MORINAGA, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

In Vivo March 2026, 40 (2) 803-812; DOI: https://doi.org/10.21873/invivo.14238
Open Access
Transcriptome Analysis of the Effects of X-Ray Radiotherapy on Non-small-cell Lung Cancer Using Next-generation Sequencing
SERHAT ARAS, TUĞBA KUL KÖPRÜLÜ, BURÇIN ERKAL ÇAM, JÜLIDE BALKAN, ESRA ERDEM, ESRA ÇIKLER and ALTAN KARA

In Vivo September 2025, 39 (5) 2711-2727; DOI: https://doi.org/10.21873/invivo.14070
Open Access
Risk Factors for Radiation Pneumonitis and a Prognostic Instrument for Very Elderly Patients With Lung Cancer
DIRK RADES, CANSU DELIKANLI, LAURA DOEHRING, STEFAN JANSSEN, SABINE BOHNET and ELISA M. GROH

In Vivo September 2025, 39 (5) 2818-2823; DOI: https://doi.org/10.21873/invivo.14081
Open Access
Non-Invasive Direct Visualization of Luciferase-Luciferin Emitted Light Producing True Images from an Orthotopic Lung Cancer Xenograft Model in Nude Mice Using an Ultra-sensitive Low-light Camera and Optics
KOHEI MIZUTA, SEAN GALLAGHER, APRIL WANG, NEIL CHANG, SEI MORINAGA, MOTOKAZU SATO, BYUNG MO KANG and ROBERT M. HOFFMAN

In Vivo September 2024, 38 (5) 2122-2125; DOI: https://doi.org/10.21873/invivo.13674
Open Access
Progression to Lymph Node Metastasis After Spontaneous Regression of Pulmonary Adenocarcinoma Following Biopsy
KYOICHI KAIRA, HISAO IMAI, ATSUTO MOURI, OU YAMAGUCHI and HIROSHI KAGAMU

In Vivo May 2024, 38 (3) 1498-1502; DOI: https://doi.org/10.21873/invivo.13597
Open Access
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report
TAKAHIRO HIRAI, MINEHIKO INOMATA, SHUHEI MINATOYAMA, MOE HASHIZUME, NAOKI TAKATA, KANA HAYASHI, ZENTA SETO, KOTARO TOKUI, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHINICHI TANAKA, AKIRA NOGUCHI and TSUTOMU SATO

In Vivo May 2024, 38 (3) 1509-1511; DOI: https://doi.org/10.21873/invivo.13599
Open Access
Polyphyllin II (PPII) Enhances the Sensitivity of Multidrug-resistant A549/DDP Cells to Cisplatin by Modulating Mitochondrial Energy Metabolism
LIAN PENG, RENYI YANG, ZHIBING WANG, HUIYING JIAN, XIAONING TAN, JIAN LI, ZUOMEI HE, RUI HUANG, PUHUA ZENG and WENHUI GAO

In Vivo January 2024, 38 (1) 213-225; DOI: https://doi.org/10.21873/invivo.13428
Open Access
Association Between Clinicopathological Parameters and S100A8/A9 Expression According to Smoking History in Patients With Non-small Cell Lung Cancer
SUNG BAE CHO, IN KYOUNG KIM, CHANG DONG YEO and SANG HAAK LEE

In Vivo January 2024, 38 (1) 474-481; DOI: https://doi.org/10.21873/invivo.13462
Open Access
Renieramycin T Derivative DH_22 Induces p53-dependent Apoptosis in Lung Cancer Cells
INDIANA GITA ANGGRAENI, ZIN ZIN EI, DAIKI HOTTA, MASASHI YOKOYA and PITHI CHANVORACHOTE

In Vivo September 2023, 37 (5) 1960-1966; DOI: https://doi.org/10.21873/invivo.13292

Main menu

User menu

Search

Lung cancer

Pages